Ron Taylor Named Inventor Of The Year
3, 2000 -- The University of Virginia Patent Foundation
has named Ronald P. Taylor, professor of biochemistry and molecular
genetics and a member of the Beirne Carter Immunology Center, as
the Christopher J. Henderson Inventor of the Year.
a faculty member in the U.Va. School of Medicine since 1973, is
being recognized for inventions related to his research into the
treatment of diseases associated with pathogens in the bloodstream.
Taylor spent years struggling to find funding for his research because
many people were skeptical that this technology could work,"
said Robert MacWright, executive director of the U.Va. Patent Foundation.
"But his patents now prove that it does. We are confident that
EluSys Therapeutics Inc., a company formed to complete the process
of bringing this technology to market, can apply his clever designs
to saving lives and reducing suffering in unprecedented ways. We
are very pleased to recognize Rons passion and his tenacity,
and to honor him now at the beginning of what we believe will be
an exciting story of commercial and medical success."
has studied the natural mechanisms by which white and red blood
cells work to rid the bloodstream of disease. Taylors inventions,
which mimic this natural process, have potential uses in routine
health care, and in coping with diseases that currently have no
known treatment, as well as in treating victims of biological warfare,
according to MacWright.
research has been funded in part by the National Institutes of Health
and the Defense Advanced Research Projects Agency. To date, his
inventions have been licensed to EluSys Therapeutics Inc. of Pinebrook,
insists on sharing credit for his scientific progress with other
researchers in his laboratory who have contributed to the effort
in many ways. He notes in particular his gratitude to William M.
Sutherland for his scientific and moral support. "Sutherland
created the monoclonal antibodies needed for our experiments and
has played an integral and essential role in our work from the very
beginning," he said.
also expressed his appreciation for the support and advice offered
by the U.Va. Patent Foundation.
of my colleagues are working with the U.Va. Patent Foundation to
pursue the practical applications of their research," Taylor
said. "I hope that younger investigators will do so as well.
Such efforts have the potential to bring credit to the University
and enhance its well-deserved national reputation."
U.Va. Patent Foundation award recognizes an invention of notable
value to society. The criteria for selection include commercial
success (or commercial potential) and the invention's value in treating
disease, protecting the environment, as a tool for research, in
education and training, in the development of a field of science
or technology, or in helping the disadvantaged, the disabled and
Patent Foundation named the Inventor of the Year Award after Christopher
J. Henderson, president and chief financial officer of Robbins &
Henderson, a New York firm specializing in financial and related
services for institutions, in recognition of Hendersons interest
in technology transfer and commitment to the University of Virginia.
Established in 1992, the award program was conceived by Dr. Richard
Edlich, a professor of plastic surgery and biomedical engineering
at U.Va. Dr. Edlich will present the annual award to Taylor at a
dinner to be held in his honor tonight at Ednam Hall.
University of Virginia Patent Foundation is a not-for-profit corporation
affiliated with U.Va. that is responsible for licensing to business
and industry the intellectual property discovered and created in
"The Foundation has had an impressive year as a catalyst, firing
up new activities to assist high-technology entrepreneurs,"
said Gene D. Block, vice president for research and public service.
"The Corridor 1 office suite, established last fall on West
Main Street, and the soon-to-be-created Spinner Technologies, a
for-profit company, are helping to launch University-related startups
and further extend the economic benefits of University research
around the greater Charlottesville region."
more information, contact Robert MacWright at (804) 982-0378 or
Charlotte Crystal, (804) 924-6858
of Virginia scientists who have won U.S. patents since Jan. 1, 1999
Ray Taylor, et al., "Chromate-Free Protective Coatings,"
patent held by The Boeing Co., Seattle, Wash., patent issued
Chapman and L. Karla Arruda, "Molecular Cloning
of Cockroach Allergens, Amino Acid and Nucleotide Sequences
Therefore and Recombinant Expression Thereof," U.Va. Patent
W. K. Chung, Haiyen E. Zhau and Shi-ming Chang, "Androgen-Repressed
Metastatic Human Prostate Cancer Cell Line," U.Va. Patent
M. Linden and Gail W. Sullivan, "Method for
Treating Inflammatory Diseases with A2A Adenosine Receptor Agonists,"
U.Va. Patent Foundation, 3/2/99
P. Taylor, Polly J. Ferguson, Edward N. Martin Jr., William
M. Sutherland, et al., "Antigen-Based Heteropolymers
and Method for Treating Autoimmune Diseases Using the Same,"
U.Va. Patent Foundation, 3/9/99
C. Hazen, et al., "Antifungal and Antibacterial Susceptibility
Assay," The Research and Development Institute Inc., Bozeman,
Mont., U.Va. Patent Foundation, 3/23/99
W. P. Hsu, Mark Lee and Bascom S. Dearer Jr., "
Nanometer Distance Regulation Using Electromechanical Power
Dissipation," U.Va. Patent Foundation, 3/23/99
A. Petri Jr., R. Randolph Vines, Jay E. Purdy and Barbara
J. Mann, "Transfection of Enteric Parasites,"
U.Va. Patent Foundation, 4/6/99
W. Laurie, Rebecca A. Ogle and J. Douglas Glass,
"Diagnostic for Sjogrens Syndrome," U.Va. Patent
Ray Taylor and Patrick A. Cella, "In Situ Sensor
for Critical Corrosion Conditions in a Material," U.Va.
Patent Foundation, 4/20/99
L. Gonias and Donna J. Webb, "Chemically Modified
A-Macroglobulins, Methods of Making, and Methods of Using the
Same in Anti-Cytokine Therapy," U.Va. Patent Foundation,
L. Guerrant, Guodong D. Fang, et al., "Method of Inhibiting
Secretory Effects Caused by Cholera," U.Va. Patent Foundation,
Cominelli, Theresa Pizarro, et al., "Method of Diagnosing
Predisposition for Ulcerative Colitis in Jewish Population by
Detection of Interleukin-1 Receptor Antagonist Polymorphism,"
Cedars-Sinai Medical Center, Los Angeles, Calif., 8/24/99
I. Lobo, "Method for Detection of Anti-HLA Antibodies,"
U.Va. Patent Foundation, 10/5/99
Liu, "Radiation-Shielding, Interpolative-Sampling Technique
for High Spatial Resolution Digital Radiography," U.Va.
Patent Foundation, 10/12/99
O. Thorner, Bruce D. Gaylinn, et al., "Isolation and
Characterization of the Growth Hormone Releasing Hormone Receptor,"
U.Va. Patent Foundation and American Cyanamid Co., Wayne, N.J.,10/26/99
D. Teates, "Reusable Shielded Marker for Nuclear Medicine
Imaging," U.Va. Patent Foundation, 11/16/99
Lanzino, et al., "Method for Treating Cerebral Vasospasm
and Cerebral Ischemia Using Iron Chelators and Pharmaceutical
Compositions Therefor," U.Va. Patent Foundation, 12/21/99